Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · women with perineal pain in the early postpartum period
Aspirin may leads to higher adequate pain relief as reported by the woman (4 to 8 hours) compared with placebo (low certainty).
1 finding from 1 review
Need for additional pain relief (4 to 8 hours) · women with perineal pain in the early postpartum period
It is very uncertain whether aspirin changes need for additional pain relief (4 to 8 hours) compared with placebo (very low certainty).
1 finding from 1 review
Maternal adverse events · women with perineal pain in the early postpartum period
It is very uncertain whether aspirin changes maternal adverse effects (4 to 8 hours) compared with placebo (very low certainty).
1 finding from 1 review
Neonatal drug adverse effects · women with perineal pain in the early postpartum period
1 finding from 1 review
Perineal pain at six weeks postpartum · women with perineal pain in the early postpartum period
1 finding from 1 review
Live birth · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
It is very uncertain whether aspirin changes live birth compared with placebo (very low certainty).
1 finding from 1 review
Pre‐eclampsia · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
It is very uncertain whether aspirin changes pre‐eclampsia compared with placebo (very low certainty).
1 finding from 1 review
Adverse events in the mother ‐ Bleeding · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
It is very uncertain whether aspirin changes adverse events in the mother ‐ Bleeding compared with placebo (very low certainty).
1 finding from 1 review
Venous thromboembolism · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Arterial thromboembolism · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pregnancy loss · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
It is very uncertain whether aspirin changes pregnancy loss compared with placebo (very low certainty).
1 finding from 1 review
Preterm delivery of a live infant · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
It is very uncertain whether aspirin changes preterm delivery of a live infant compared with placebo (very low certainty).
1 finding from 1 review
Intrauterine growth restriction · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
It is very uncertain whether aspirin changes intrauterine growth restriction compared with placebo (very low certainty).
1 finding from 1 review
Adverse events in the child ‐ Congenital malformations · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
It is very uncertain whether aspirin changes adverse events in the child ‐ Congenital malformations compared with placebo (very low certainty).
1 finding from 1 review